PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Kidney Research and Clinical Practice10.23876/j.krcp.21.0372021403344-354Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agentsMin Hee Honghttp://www.krcp-ksn.org/upload/pdf/j-krcp-21-037.pdf, http://www.krcp-ksn.org/journal/view.php?doi=10.23876/j.krcp.21.037, http://www.krcp-ksn.org/upload/pdf/j-krcp-21-037.pdf
International Journal of Antimicrobial Agents10.1016/s0924-8579(97)00366-x199783215-216Netilmicin serum levels in 138 cancer patients. Do they predict nephrotoxicity or therapeutic failure?V. Kcmery, J. Halko, K. Kralovicova, S. Grausova, K. Stopkova, J. Netriovahttps://api.elsevier.com/content/article/PII:S092485799700366X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092485799700366X?httpAccept=text/plain
Cancer Management and Research10.2147/cmar.s350242014225Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancerFelicity Mayhttps://www.dovepress.com/getfile.php?fileID=20173
Infectious Agents and Cancer10.1186/1750-9378-5-s1-a4920105S1KSHV-mediated ROS induction defines novel therapeutic targets in Kaposi's sarcomaLucas E Cavallin, Qi Ma, Pascal Goldschmidt-Clermont, Enrique A Mesrihttp://link.springer.com/content/pdf/10.1186/1750-9378-5-S1-A49.pdf, http://link.springer.com/article/10.1186/1750-9378-5-S1-A49/fulltext.html, http://link.springer.com/content/pdf/10.1186/1750-9378-5-S1-A49.pdf
Cancer Treatment Reviews10.1016/j.ctrv.2017.09.002201760120-129Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory diseaseAlessandro Broccoli, Lisa Argnani, Pier Luigi Zinzanihttps://api.elsevier.com/content/article/PII:S0305737217301469?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737217301469?httpAccept=text/plain
Cancer Treatment Reviews10.1016/j.ctrv.2017.10.00720176161-69Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory diseaseLisa Argnani, Alessandro Broccoli, Pier Luigi Zinzanihttps://api.elsevier.com/content/article/PII:S0305737217301639?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737217301639?httpAccept=text/plain
Drugs & Aging10.1007/s40266-018-0519-5201835293-115Pharmacotherapeutic Management of Breast Cancer in Elderly Patients: The Promise of Novel AgentsCatherine Terret, Chiara Russohttp://link.springer.com/article/10.1007/s40266-018-0519-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40266-018-0519-5.pdf, http://link.springer.com/content/pdf/10.1007/s40266-018-0519-5.pdf
Discovery and Development of Anti-Breast Cancer Agents from Natural Products10.1016/b978-0-12-821277-6.00008-82021197-229Phytoestrogens as Novel Therapeutic Molecules Against Breast CancerSayanta Dutta, Sushweta Mahalanobish, Parames C. Silhttps://api.elsevier.com/content/article/PII:B9780128212776000088?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B9780128212776000088?httpAccept=text/plain
Investigational New Drugs10.1007/s10637-016-0322-22016343364-370Effect of regulation reform on clinical trials for registering novel therapeutic agents in Taiwan: a chronological analysisI-Chen Sun, Horng-Shing Shy, Tzu-Ya Liaohttp://link.springer.com/content/pdf/10.1007/s10637-016-0322-2.pdf, http://link.springer.com/article/10.1007/s10637-016-0322-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s10637-016-0322-2
Journal of Experimental Pharmacology10.2147/jep.s7804201121Novel compounds in the treatment of lung cancer: current and developing therapeutic agentsRudi Bao, Chanhttps://www.dovepress.com/getfile.php?fileID=9301